Introduction: Fungal infections occur frequently in lung transplant patient
s, with the highest risk being in the early postoperative period (the initi
al hospitalization after lung transplantation). Aspergillus is responsible
for more than half of all fungal infections, and Aspergillus has even been
considered a contraindication for lung transplantation because of its diffi
cult therapy and frequently fatal outcome. The aim of this article is to ev
aluate the success of an antifungal prophylaxis protocol to prevent fungal
infection in the immediate postoperative period in lung transplant recipien
ts,
Material and Methods: From March 1994 to March 1997, we performed 52 lung t
ransplants in 31 men and 21 women who received antifungal prophylaxis with
fluconazole, 400 mg/d, and aerosolized amphotericin B, 0.6 mg/kg/d, during
the postoperative period.
Results: The mean(a SD) postoperative period duration was 49 +/- 27.5 days.
No fungal infections were observed during this period, and all patients pr
ovided negative cultures. We also found no toxicity related to antifungal d
rugs, The dose of cyclosporine was easily adjusted in every recipient accor
ding to blood levels so that effective immunosuppression was not compromise
d.
Discussion: In our study, the removal of the lungs and antifungal prophylax
is with fluconazole and aerosolized amphotericin B prevented fungal infecti
on in the postoperative period in all 52 lung easily adjusted in every tran
splant recipients.